113 related articles for article (PubMed ID: 38697493)
1. Targeted degradation of NDUFS1 by agrimol B promotes mitochondrial ROS accumulation and cytotoxic autophagy arrest in hepatocellular carcinoma.
Dong L; Luo L; Wang Z; Lian S; Wang M; Wu X; Fan J; Zeng Y; Li S; Lv S; Yang Y; Chen R; Shen E; Yang W; Li C; Wang K
Free Radic Biol Med; 2024 Apr; 220():111-124. PubMed ID: 38697493
[TBL] [Abstract][Full Text] [Related]
2. LncRNA CRNDE Promotes ATG4B-Mediated Autophagy and Alleviates the Sensitivity of Sorafenib in Hepatocellular Carcinoma Cells.
Chen L; Sun L; Dai X; Li T; Yan X; Zhang Y; Xiao H; Shen X; Huang G; Xiang W; Zhang Y; Tan D; Yang S; Nie Y; Huang X; Lian J; He F
Front Cell Dev Biol; 2021; 9():687524. PubMed ID: 34409031
[TBL] [Abstract][Full Text] [Related]
3. CDK9 inhibition blocks the initiation of PINK1-PRKN-mediated mitophagy by regulating the SIRT1-FOXO3-BNIP3 axis and enhances the therapeutic effects involving mitochondrial dysfunction in hepatocellular carcinoma.
Yao J; Wang J; Xu Y; Guo Q; Sun Y; Liu J; Li S; Guo Y; Wei L
Autophagy; 2022 Aug; 18(8):1879-1897. PubMed ID: 34890308
[TBL] [Abstract][Full Text] [Related]
4. Agrimol B inhibits colon carcinoma progression by blocking mitochondrial function through the PGC-1α/NRF1/TFAM signaling pathway.
Xiang D; Yang W; Fang Z; Mao J; Yan Q; Li L; Tan J; Yu C; Qian J; Tang D; Pan X; Cheng H; Sun D
Front Oncol; 2022; 12():1055126. PubMed ID: 36591497
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular carcinoma cells downregulate NADH:Ubiquinone Oxidoreductase Subunit B3 to maintain reactive oxygen species homeostasis.
Zhang Z; Zhao Q; Wang Z; Xu F; Liu Y; Guo Y; Li C; Liu T; Zhao Y; Tang X; Zhang J
Hepatol Commun; 2024 Mar; 8(3):. PubMed ID: 38437062
[TBL] [Abstract][Full Text] [Related]
6. Increased mitochondrial fission promotes autophagy and hepatocellular carcinoma cell survival through the ROS-modulated coordinated regulation of the NFKB and TP53 pathways.
Huang Q; Zhan L; Cao H; Li J; Lyu Y; Guo X; Zhang J; Ji L; Ren T; An J; Liu B; Nie Y; Xing J
Autophagy; 2016 Jun; 12(6):999-1014. PubMed ID: 27124102
[TBL] [Abstract][Full Text] [Related]
7. ADRB2 signaling promotes HCC progression and sorafenib resistance by inhibiting autophagic degradation of HIF1α.
Wu FQ; Fang T; Yu LX; Lv GS; Lv HW; Liang D; Li T; Wang CZ; Tan YX; Ding J; Chen Y; Tang L; Guo LN; Tang SH; Yang W; Wang HY
J Hepatol; 2016 Aug; 65(2):314-24. PubMed ID: 27154061
[TBL] [Abstract][Full Text] [Related]
8. Genome-scale CRISPRa screening identifies MTX1 as a contributor for sorafenib resistance in hepatocellular carcinoma by augmenting autophagy.
Li L; Yu S; Hu Q; Hai Y; Li Y
Int J Biol Sci; 2021; 17(12):3133-3144. PubMed ID: 34421355
[TBL] [Abstract][Full Text] [Related]
9. Icaritin with autophagy/mitophagy inhibitors synergistically enhances anticancer efficacy and apoptotic effects through PINK1/Parkin-mediated mitophagy in hepatocellular carcinoma.
Luo P; An Y; He J; Xing X; Zhang Q; Liu X; Chen Y; Yuan H; Chen J; Wong YK; Huang J; Gong Z; Du Q; Xiao W; Wang J
Cancer Lett; 2024 Apr; 587():216621. PubMed ID: 38242198
[TBL] [Abstract][Full Text] [Related]
10. Withaferin A, a natural thioredoxin reductase 1 (TrxR1) inhibitor, synergistically enhances the antitumor efficacy of sorafenib through ROS-mediated ER stress and DNA damage in hepatocellular carcinoma cells.
Chen X; Zhu N; Wu Y; Zhang Y; Zhang Y; Jin K; Zhou Z; Chen G; Wang J
Phytomedicine; 2024 Jun; 128():155317. PubMed ID: 38537439
[TBL] [Abstract][Full Text] [Related]
11. The role of the key autophagy kinase ULK1 in hepatocellular carcinoma and its validation as a treatment target.
Xue ST; Li K; Gao Y; Zhao LY; Gao Y; Yi H; Jiang JD; Li ZR
Autophagy; 2020 Oct; 16(10):1823-1837. PubMed ID: 31986961
[TBL] [Abstract][Full Text] [Related]
12. Coptisine induces autophagic cell death through down-regulation of PI3K/Akt/mTOR signaling pathway and up-regulation of ROS-mediated mitochondrial dysfunction in hepatocellular carcinoma Hep3B cells.
Kim SY; Hwangbo H; Kim MY; Ji SY; Lee H; Kim GY; Kwon CY; Leem SH; Hong SH; Cheong J; Choi YH
Arch Biochem Biophys; 2021 Jan; 697():108688. PubMed ID: 33227289
[TBL] [Abstract][Full Text] [Related]
13. Loss of NDUFS1 promotes gastric cancer progression by activating the mitochondrial ROS-HIF1α-FBLN5 signaling pathway.
Chen T; Li D; Wang Y; Shen X; Dong A; Dong C; Duan K; Ren J; Li W; Shu G; Yang J; Xie Y; Qian F; Zhou J
Br J Cancer; 2023 Oct; 129(8):1261-1273. PubMed ID: 37644092
[TBL] [Abstract][Full Text] [Related]
14. Sorafenib Inhibits Ribonucleotide Reductase Regulatory Subunit M2 (RRM2) in Hepatocellular Carcinoma Cells.
Yang PM; Lin LS; Liu TP
Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31936661
[TBL] [Abstract][Full Text] [Related]
15. Stachydrine hydrochloride inhibits hepatocellular carcinoma progression via LIF/AMPK axis.
Bao X; Liu Y; Huang J; Yin S; Sheng H; Han X; Chen Q; Wang T; Chen S; Qiu Y; Zhang C; Yu H
Phytomedicine; 2022 Jun; 100():154066. PubMed ID: 35366490
[TBL] [Abstract][Full Text] [Related]
16. Human menstrual blood-derived stem cells reverse sorafenib resistance in hepatocellular carcinoma cells through the hyperactivation of mitophagy.
Zhou S; Liu Y; Zhang Q; Xu H; Fang Y; Chen X; Fu J; Yuan Y; Li Y; Yuan L; Xiang C
Stem Cell Res Ther; 2023 Apr; 14(1):58. PubMed ID: 37005657
[TBL] [Abstract][Full Text] [Related]
17. Pyrimethamine upregulates BNIP3 to interfere SNARE-mediated autophagosome-lysosomal fusion in hepatocellular carcinoma.
Wang J; Su Q; Chen K; Wu Q; Ren J; Tang W; Hu Y; Zhu Z; Cheng C; Tu K; He H; Zhang Y
J Pharm Anal; 2024 Feb; 14(2):211-224. PubMed ID: 38464783
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of autophagy enhances anticancer effects of bevacizumab in hepatocarcinoma.
Guo XL; Li D; Sun K; Wang J; Liu Y; Song JR; Zhao QD; Zhang SS; Deng WJ; Zhao X; Wu MC; Wei LX
J Mol Med (Berl); 2013 Apr; 91(4):473-83. PubMed ID: 23052483
[TBL] [Abstract][Full Text] [Related]
19. Hydroxychloroquine (HCQ) Modulates Autophagy and Oxidative DNA Damage Stress in Hepatocellular Carcinoma to Overcome Sorafenib Resistance via TLR9/SOD1/hsa-miR-30a-5p/Beclin-1 Axis.
Chen MY; Yadav VK; Chu YC; Ong JR; Huang TY; Lee KF; Lee KH; Yeh CT; Lee WH
Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34203465
[TBL] [Abstract][Full Text] [Related]
20. Peroxiredoxin 1 is essential for natamycin-triggered apoptosis and protective autophagy in hepatocellular carcinoma.
An Y; Jiang J; Zhou L; Shi J; Jin P; Li L; Peng L; He S; Zhang W; Huang C; Zou B; Xie N
Cancer Lett; 2021 Aug; 521():210-223. PubMed ID: 34428517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
